Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Maniar, Manoj
46  Ergebnisse:
Personensuche X
?
1

Serum microRNA profile of rhesus macaques following ionizin..:

Russ, Eric ; Fatanmi, Oluseyi O. ; Wise, Stephen Y....
Scientific Reports.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

Analysis of the Proteomic Profile in Serum of Irradiated No..:

Carpenter, Alana D. ; Li, Yaoxiang ; Janocha, Brianna L....
Journal of Proteome Research.  22 (2023)  4 - p. 1116-1126 , 2023
Link: https://doi.org/10.1021/..
 
?
3

Analysis of the metabolomic profile in serum of irradiated ..:

Li, Yaoxiang ; Girgis, Michael ; Wise, Stephen Y....
Scientific Reports.  11 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
4

Rigosertib in combination with azacitidine in patients with..:

Navada, Shyamala C. ; Garcia-Manero, Guillermo ; OdchimarReissig, Rosalie...
Leukemia Research.  94 (2020)  - p. 106369 , 2020
Link: https://doi.org/10.1016/..
 
?
5

Effect of Gender on the Pharmacokinetics of ON 123300, A Du..:

Mudunuru, Jennypher ; Ren, Chen ; Taft, David R..
European Journal of Drug Metabolism and Pharmacokinetics.  44 (2019)  4 - p. 531-538 , 2019
Link: https://doi.org/10.1007/..
 
?
6

Determination of Degradation Kinetics and Effect of Anion E..:

Patel, Hardikkumar H. ; Maniar, Manoj ; Ren, Chen.
AAPS PharmSciTech.  19 (2017)  1 - p. 93-100 , 2017
Link: https://doi.org/10.1208/..
 
?
7

Clinical activity and safety of the dual pathway inhibitor ..:

Silverman, Lewis R. ; Greenberg, Peter ; Raza, Azra...
Hematological Oncology.  33 (2014)  2 - p. 57-66 , 2014
Link: https://doi.org/10.1002/..
 
?
8

Determination of intestinal permeability of rigosertib (ON ..:

White, Michael P ; Babayeva, Mariana ; Taft, David R.
Journal of Pharmacy and Pharmacology.  65 (2013)  7 - p. 960-969 , 2013
Link: https://doi.org/10.1111/..
 
?
9

Disposition of ON 01210.Na (Ex-RAD(R)), a Novel Radioprotec..:

Tamhane, Mitalee ; Maniar, Manoj ; Ren, Chen..
Journal of Pharmaceutical Sciences.  102 (2013)  2 - p. 732-740 , 2013
Link: https://doi.org/10.1002/..
 
?
10

Phase I clinical trial of oral rigosertib in patients with ..:

Komrokji, Rami S. ; Raza, Azra ; Lancet, Jeffrey E....
British Journal of Haematology.  162 (2013)  4 - p. 517-524 , 2013
Link: https://doi.org/10.1111/..
 
?
11

Directed therapy for patients with myelodysplastic syndrome..:

Olnes, Matthew J. ; Shenoy, Aarthie ; Weinstein, Barbara...
Leukemia Research.  36 (2012)  8 - p. 982-989 , 2012
Link: https://doi.org/10.1016/..
 
?
12

Administration of ON 01210.Na after exposure to ionizing ra..:

Suman, Shubhankar ; Maniar, Manoj ; Fornace Jr, Albert J.
Radiation Oncology.  7 (2012)  1 - p. , 2012
Link: https://doi.org/10.1186/..
 
?
13

Radioprotective Effects of ON 01210.Na upon Oral Administra..:

SUMAN, Shubhankar ; DATTA, Kamal ; DOIRON, Kathryn...
Journal of Radiation Research.  53 (2012)  3 - p. 368-376 , 2012
Link: https://doi.org/10.1269/..
 
?
14

Effects of formulation and route of administration on the s..:

Chun, Amy W. ; Freshwater, Robert E. ; Taft, David R...
Biopharmaceutics & Drug Disposition.  32 (2011)  2 - p. 99-111 , 2011
Link: https://doi.org/10.1002/..
 
?
15

Radiation Protection by a New Chemical Entity, Ex-Rad™: Eff..:

Ghosh, Sanchita P. ; Perkins, Michael W. ; Hieber, Kevin...
Radiation Research.  171 (2009)  2 - p. 173-179 , 2009
Link: https://www.jstor.org/st..
 
1-15